ImmunityBio, Inc. Common Stock
IBRX
IBRX: ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.
moreShow IBRX Financials
Recent trades of IBRX by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Daniel Goldman House / D | Sale $1,001 - $15,000 | Mar. 06, 2023 |
Recently reported changes by institutional investors
Quarterly net insider trading by IBRX's directors and management
Government lobbying spending instances
-
$45,000 Oct 08, 2022 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$45,000 Jul 19, 2022 Issue: Health Issues Medical/Disease Research/Clinical Labs
-
$60,000 Apr 09, 2022 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$60,000 Jan 17, 2022 Issue: Health Issues Medical/Disease Research/Clinical Labs
New patents grants
-
Patent Title: Modified nk-92 hank003 cells for the clinic Sep. 12, 2023
-
Patent Title: Fc-epsilon car May. 09, 2023
-
Patent Title: Chimeric antigen receptor-modified nk-92 cells Jan. 10, 2023
-
Patent Title: Mononuclear cell derived nk cells Sep. 27, 2022
-
Patent Title: Generating cik nkt cells from cord blood Jun. 07, 2022
-
Patent Title: Tumoricidal and antimicrobial compositions and methods Apr. 19, 2022
-
Patent Title: Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors Jan. 25, 2022
-
Patent Title: Tumoricidal and antimicrobial compositions and methods Jan. 04, 2022
-
Patent Title: Genetically modified nk-92 cells and monoclonal antibodies for the treatment of cancer Dec. 28, 2021
-
Patent Title: Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies Sep. 28, 2021
Federal grants, loans, and purchases
Followers on IBRX's company Twitter account
Number of mentions of IBRX in WallStreetBets Daily Discussion
Recent insights relating to IBRX
Recent picks made for IBRX stock on CNBC
ETFs with the largest estimated holdings in IBRX
Flights by private jets registered to IBRX